284 related articles for article (PubMed ID: 16905695)
21. [Argon plasma coagulation in Barrett's esophagus].
Nomura T; Yamashita K; Miyashita M; Tajiri T
Nihon Rinsho; 2005 Aug; 63(8):1458-62. PubMed ID: 16101240
[TBL] [Abstract][Full Text] [Related]
22. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.
Pech O; Behrens A; May A; Nachbar L; Gossner L; Rabenstein T; Manner H; Guenter E; Huijsmans J; Vieth M; Stolte M; Ell C
Gut; 2008 Sep; 57(9):1200-6. PubMed ID: 18460553
[TBL] [Abstract][Full Text] [Related]
23. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma.
Van Laethem JL; Jagodzinski R; Peny MO; Cremer M; Devière J
Endoscopy; 2001 Mar; 33(3):257-61. PubMed ID: 11293760
[TBL] [Abstract][Full Text] [Related]
24. Effects of low-power argon plasma coagulation thermoablation of Barrett's epithelium on oesophageal motility.
Basu KK; Talwar V; de Caestecker JS
Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):733-7. PubMed ID: 16772830
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of Barrett esophagus with argon plasma coagulation with acid suppression--a prospective study].
Martin WR; Jakobs R; Spiethoff A; Maass S; Riemann JF
Z Gastroenterol; 1999 Sep; 37(9):779-84. PubMed ID: 10522363
[TBL] [Abstract][Full Text] [Related]
26. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II).
Phoa KN; Pouw RE; Bisschops R; Pech O; Ragunath K; Weusten BL; Schumacher B; Rembacken B; Meining A; Messmann H; Schoon EJ; Gossner L; Mannath J; Seldenrijk CA; Visser M; Lerut T; Seewald S; ten Kate FJ; Ell C; Neuhaus H; Bergman JJ
Gut; 2016 Apr; 65(4):555-62. PubMed ID: 25731874
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic therapy for high-grade dysplasia in Barrett's esophagus: ablate, resect, or both?
Sharma P; Wani S; Rastogi A
Gastrointest Endosc; 2007 Sep; 66(3):469-74. PubMed ID: 17725936
[No Abstract] [Full Text] [Related]
28. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.
Morris CD; Byrne JP; Armstrong GR; Attwood SE
Br J Surg; 2001 Oct; 88(10):1357-62. PubMed ID: 11578292
[TBL] [Abstract][Full Text] [Related]
29. Management of Barrett's oesophagus, dysplasia and early adenocarcinoma.
Pech O; Gossner L; May A; Ell C
Best Pract Res Clin Gastroenterol; 2001 Apr; 15(2):267-84. PubMed ID: 11355915
[TBL] [Abstract][Full Text] [Related]
30. Neoplastic Barrett's oesophagus and long-term follow-up after endoscopic therapy: complete histological eradication of Barrett associated with high-grade dysplasia significantly decreases neoplasia relapse.
Caillol F; Godat S; Autret A; Bories E; Pesenti C; Ratone JP; Poizat F; Guiramand J; Delpero JR; Giovannini M
Surg Endosc; 2016 Dec; 30(12):5410-5418. PubMed ID: 27129553
[TBL] [Abstract][Full Text] [Related]
31. High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice.
Thomas T; Richards CJ; de Caestecker JS; Robinson RJ
Aliment Pharmacol Ther; 2005 Mar; 21(6):747-55. PubMed ID: 15771761
[TBL] [Abstract][Full Text] [Related]
32. Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation.
Manner H; May A; Miehlke S; Dertinger S; Wigginghaus B; Schimming W; Krämer W; Niemann G; Stolte M; Ell C
Am J Gastroenterol; 2006 Aug; 101(8):1762-9. PubMed ID: 16817835
[TBL] [Abstract][Full Text] [Related]
33. High-grade dysplasia in Barrett's oesophagus.
Wright TA
Br J Surg; 1997 Jun; 84(6):760-6. PubMed ID: 9189080
[TBL] [Abstract][Full Text] [Related]
34. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
35. [Endoscopic argon plasma coagulation of Barrett mucosa].
Brand B; Porthun M; von Schrenck T; Matsui U; Bohnacker S; Jäckle S; Thonke F; Seitz U; Soehendra N
Zentralbl Chir; 2000; 125(5):437-42. PubMed ID: 10929628
[TBL] [Abstract][Full Text] [Related]
36. [Barrett's esophagus: endoscopic treatment of high-grade dysplasia and early cancer].
Bergman JJ; Marsman WA; Krishnadath KK; Fockens P; van Lanschot JJ; Tytgat GN
Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2275-81. PubMed ID: 14655293
[TBL] [Abstract][Full Text] [Related]
37. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
[TBL] [Abstract][Full Text] [Related]
38. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
39. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
40. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry.
Ganz RA; Overholt BF; Sharma VK; Fleischer DE; Shaheen NJ; Lightdale CJ; Freeman SR; Pruitt RE; Urayama SM; Gress F; Pavey DA; Branch MS; Savides TJ; Chang KJ; Muthusamy VR; Bohorfoush AG; Pace SC; DeMeester SR; Eysselein VE; Panjehpour M; Triadafilopoulos G;
Gastrointest Endosc; 2008 Jul; 68(1):35-40. PubMed ID: 18355819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
